MO SB 1569
died on adjournmentSB 1569 - This act requires health benefit plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2027, to provide coverage for the treatment of perimenopause, menopause, and post-menopause, as described in the act. The coverage shall be limited to those drugs and medications that have been approved by the U.S. Food and Drug Administration and shall not be subject to any greater deductible or co-payment than other similar health care services provided by the health benefit plan. TAYLOR MIDDLETON
Missouri · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did MO SB 1569 pass?
No. MO SB 1569 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-05): Second Read and Referred S Insurance and Banking Committee
What is MO SB 1569 about?
MO SB 1569 is a bill in the 2026 Regular Session titled “SB 1569 - This act requires health benefit plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2027, to provide coverage for the treatment of perimenopause, menopause, and post-menopause, as described in the act. The coverage shall be limited to those drugs and medications that have been approved by the U.S. Food and Drug Administration and shall not be subject to any greater deductible or co-payment than other similar health care services provided by the health benefit plan. TAYLOR MIDDLETON”.
Who sponsors MO SB 1569?
Lewis, Patty is the primary sponsor of MO SB 1569.
Description
SB 1569 - This act requires health benefit plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2027, to provide coverage for the treatment of perimenopause, menopause, and post-menopause, as described in the act. The coverage shall be limited to those drugs and medications that have been approved by the U.S. Food and Drug Administration and shall not be subject to any greater deductible or co-payment than other similar health care services provided by the health benefit plan. TAYLOR MIDDLETON
- Introduced
- —
- Latest action
- 2026-02-05 — Second Read and Referred S Insurance and Banking Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- Lewis, Pattyprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-02-05
Second Read and Referred S Insurance and Banking Committee
reading-2,referral-committee
2026-01-20
S First Read
reading-1
Versions
- 6300S.01I - IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:25:15.077812Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MO&identifier=SB 1569. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.